Table 3 A summary of the effects of both treatments on the primary parameters

Result

95% CI

Result

95% CI

MACE

0.90 RR

0.63–1.30

1.06 RR

0.87–1.29

Safer trend with ^AutoMSCs treatment

LVEF

2.17%

− 1.33–5.67

0.86%

− 1.21–2.94

Non-significant difference between groups, with a trend of superior efficacy with ^AutoMSCs treatment

6-MWD

31.17 m

− 8.91–71.25

31.88 m

5.03–58.74

Significant improvement with ^AlloMSCs treatment compared to non-significant improvement with ^AutoMSCs treatment